About Dominic Eisinger, Ph.D.
Global Head of Sales - Rules-Based Medicine
Dr. Eisinger combines his scientific expertise with business, market, and customer insights to achieve sustained commercial impact and value.
Dr. Eisinger leads global sales, marketing, new product development, and partnership strategies at Rules-Based Medicine and is the company’s lead scientific speaker on pharmacodynamic protein biomarker applications in drug development. Prior to RBM, he was President of Multiplex Biosciences, a multiplex immunoassay development and manufacturing company he founded which was acquired by RBM in 2006. Dr. Eisinger also started and directed Upstate Cell Signaling Solutions’ multiplex business unit from its inception in 2000 until 2006 and through several acquisitions is now part of the Milliplex® product line at Millipore-Sigma. Dr. Eisinger earned his PhD in cell and molecular biology from the University of Vermont, and after a two-year post-doctoral fellowship in biochemistry at Dartmouth Medical School, he joined Argonex Pharmaceuticals as R&D manager in tumor antigen discovery.